Morgan Stanley analyst Michael Ulz downgraded AlloVir to Underweight from Equal Weight with a 50c price target.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on ALVR:
- Karuna downgraded, Arm target raised: Wall Street’s top analyst calls
- AlloVir downgraded to Underperform from Buy at BofA
- AlloVir downgraded to Equal Weight from Overweight at Morgan Stanley
- AlloVir downgraded to Market Perform from Outperform at Leerink
- Nike downgraded, Waste Management upgraded: Wall Street’s top analyst calls